Schirizzi, A.; De Leonardis, G.; Lorusso, V.; Donghia, R.; Rizzo, A.; Vallarelli, S.; Ostuni, C.; Troiani, L.; Lolli, I.R.; Giannelli, G.;
et al. Targeting Angiogenesis in the Era of Biliary Tract Cancer Immunotherapy: Biological Rationale, Clinical Implications, and Future Research Avenues. Cancers 2023, 15, 2376.
https://doi.org/10.3390/cancers15082376
AMA Style
Schirizzi A, De Leonardis G, Lorusso V, Donghia R, Rizzo A, Vallarelli S, Ostuni C, Troiani L, Lolli IR, Giannelli G,
et al. Targeting Angiogenesis in the Era of Biliary Tract Cancer Immunotherapy: Biological Rationale, Clinical Implications, and Future Research Avenues. Cancers. 2023; 15(8):2376.
https://doi.org/10.3390/cancers15082376
Chicago/Turabian Style
Schirizzi, Annalisa, Giampiero De Leonardis, Vincenza Lorusso, Rossella Donghia, Alessandro Rizzo, Simona Vallarelli, Carmela Ostuni, Laura Troiani, Ivan Roberto Lolli, Gianluigi Giannelli,
and et al. 2023. "Targeting Angiogenesis in the Era of Biliary Tract Cancer Immunotherapy: Biological Rationale, Clinical Implications, and Future Research Avenues" Cancers 15, no. 8: 2376.
https://doi.org/10.3390/cancers15082376
APA Style
Schirizzi, A., De Leonardis, G., Lorusso, V., Donghia, R., Rizzo, A., Vallarelli, S., Ostuni, C., Troiani, L., Lolli, I. R., Giannelli, G., Ricci, A. D., D’Alessandro, R., & Lotesoriere, C.
(2023). Targeting Angiogenesis in the Era of Biliary Tract Cancer Immunotherapy: Biological Rationale, Clinical Implications, and Future Research Avenues. Cancers, 15(8), 2376.
https://doi.org/10.3390/cancers15082376
